Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Bell

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Introduction to Oncolytic VirotherapyChristine E Engeland, John C Bell
Oncolytic Virotherapy|August 12, 2016
Cell carriers for oncolytic viruses: current challenges and future directionsDominic G Roy, John C Bell
Journal of Molecular Medicine (Berlin, Germany)|August 6, 2016
Oncolytic viruses-immunotherapeutics on the riseBrian A Keller, John C Bell
Journal of Medical Imaging and Radiation Sciences|May 5, 2019
Oncolytic Viruses: A New Weapon to Fight CancerChristopher W Brown, John C Bell
Cytokine & Growth Factor Reviews|March 16, 2010
United virus: the oncolytic tag-team against cancer!Fabrice Le Boeuf, John C Bell
Cancer Cell|August 16, 2017
A Viro-Immunotherapy Triple Play for the Treatment of GlioblastomaJohn C Bell, Carolina S Ilkow
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C Bell
Cancer Cell|August 2, 2003
Getting oncolytic virus therapies off the groundJohn C Bell, Brian Lichty, David Stojdl
Molecular Therapy. Oncology|March 19, 2026
Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virusStephen Boulton, Siddharth Singh, John C Bell
Current Opinion in Molecular Therapeutics|January 27, 2009
Diplomatic immunity: turning a foe into an allyKelley A Parato, Brian D Lichty, John C Bell
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Introduction to Oncolytic VirotherapyChristine E Engeland, John C Bell
Oncolytic Virotherapy|August 12, 2016
Cell carriers for oncolytic viruses: current challenges and future directionsDominic G Roy, John C Bell
Journal of Molecular Medicine (Berlin, Germany)|August 6, 2016
Oncolytic viruses-immunotherapeutics on the riseBrian A Keller, John C Bell
Journal of Medical Imaging and Radiation Sciences|May 5, 2019
Oncolytic Viruses: A New Weapon to Fight CancerChristopher W Brown, John C Bell
Cytokine & Growth Factor Reviews|March 16, 2010
United virus: the oncolytic tag-team against cancer!Fabrice Le Boeuf, John C Bell
Cancer Cell|August 16, 2017
A Viro-Immunotherapy Triple Play for the Treatment of GlioblastomaJohn C Bell, Carolina S Ilkow
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C Bell
Cancer Cell|August 2, 2003
Getting oncolytic virus therapies off the groundJohn C Bell, Brian Lichty, David Stojdl
Molecular Therapy. Oncology|March 19, 2026
Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virusStephen Boulton, Siddharth Singh, John C Bell
Current Opinion in Molecular Therapeutics|January 27, 2009
Diplomatic immunity: turning a foe into an allyKelley A Parato, Brian D Lichty, John C Bell
Pageof 20